News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Proteo Inc. (PTEO.OB)/Proteo Biotech AG (PTEO.OB) - Minapharm/Rhein Minapharm Biogenetics SAE: Proteo Biotech AG (PTEO.OB), Germany and Minapharm, Egypt Enter into Development and License Agreement for Elafin


8/9/2007 1:28:30 PM

IRVINE, Calif./KIEL, Germany/CAIRO, Egypt--(BUSINESS WIRE)--Proteo, Inc. (OTCBB: PTEO; Frankfurt Freiverkehr: WKN: 925981) and its wholly-owned subsidiary Proteo Biotech AG together with Minapharm Pharmaceuticals SAE (Cairo and Alexandria Stock Exchange: MIPH) and its subsidiary Rhein Minapharm Biogenetics SAE announced today:

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES